NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Tuberculosis Week


Susan Hasty, Publisher
Table of Contents . . . March 16th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Tuberculosis Week | Other Publications

Stem Cell Research - Researchers from University of California discuss findings in stem cell research

DNA Research - Studies from L. Durnez et al have provided new data on DNA research

HIV/AIDS Co-Infection - Research from M. Velasco and co-authors in the area of HIV/AIDS co-infection published

Lymphoma - Reports outline lymphoma study results from Gaziantep University

Tuberculosis - Data on tuberculosis described by researchers at University of Ulsan

Tuberculosis - Kyushu University reports research in tuberculosis

Tuberculosis - New tuberculosis research from M.M.A. Suleiman et al outlined

Tuberculosis - New tuberculosis study results from R.M. Jones et al described

Tuberculosis - Recent studies from University of Bergen add new data to tuberculosis

Tuberculosis - Reports summarize tuberculosis study results from O. Ojo and co-researchers

Tuberculosis - Research from Kaohsiung Medical University provide new insights into tuberculosis

Tuberculosis - Scientists at Pusan National University, Medical Department target tuberculosis

Tuberculosis - Studies from Department of Agriculture yield new data on tuberculosis

Bacillus Calmette-Guerin Vaccines - Scientists at Pasteur Institute of Iran release new data on Bacillus calmette-guerin vaccines

Life Sciences - Research from Trinity College reveals new findings on life sciences

Tuberculosis Genetics - Research from Ecole polytechnique federale de Lausanne in the area of tuberculosis genetics described

Tuberculosis Genetics - Researchers at Harvard University have published new data on tuberculosis genetics

Tuberculosis Genetics - Scientists at National Institutes of Health, Department of Medical Sciences target tuberculosis genetics

Tuberculosis Immunology - Research from University of Washington, Department of Mechanical Engineering yields new findings on tuberculosis immunology

Tuberculosis Therapy - Studies from G. González-Avila et al further understanding of tuberculosis therapy

Tuberculosis Therapy - Study data from A. Alahari and co-authors update knowledge of tuberculosis therapy

Emergent BioSolutions Inc. - Emergent BioSolutions Reports Financial Results for Full Year 2008

Federation of American Societies for Experimental Biology - New discovery gives tuberculosis vaccine a shot in the arm

HIV/AIDS Co-Infection - Dr. Jim Yong Kim Appointed 17th President of Dartmouth College

HIV/AIDS Co-Infection - Global War on Drugs Takes Devastating Toll on Human Lives, Advocates Say

Lab21 Ltd - Lab21 Acquires Biotec Laboratories

Lemelson-MIT - MIT Student Develops New Innovations to Selectively Kill Cancer Cells

NIH/National Institute of Allergy and Infectious Diseases - Lab tests show two-drug combination effective against drug-resistant TB bacteria



Return to Top of Page

-----------------------
PR Login